A new project is expected to help us understand diseases such as cancer and dementia. A major partnership involving Oxford Nanopore Technologies, UK Biobank, NHS England, Genomics England, and the UK government has made this possible.
Lorna Rothery spoke to Heidi Rehm, Chair of the Global Alliance for Genomics and Health, about steps to harness quality genomic data to support disease detection and the importance of collaboration in this endeavour.
Stoyan Tchoukanov, EESC member and Rapporteur for the EESC opinion on Promoting autonomous and sustainable food production, shares with us strategies for the Common Agricultural Policy post-2027.
Hailey Coverson, Data Scientist at Bayezian, discusses the complexities of genomic data, accounting for biases and inaccuracies and AI’s potential in supporting clinical decisions in breast cancer care.
Researchers from Oxford Population Health's Cancer Epidemiology Unit have identified specific proteins in the blood that may predict a person's risk of developing various cancers over seven years before diagnosis.
A recent study led by the Molecular and Cellular Neurobiotechnology group at the Institute for Bioengineering of Catalonia (IBEC) and the University of Barcelona...
Researchers have found evidence suggesting that lifestyle factors may play a pivotal role in mitigating the risk of Alzheimer's disease, even among individuals carrying the ApoE4 gene variant.
Scientists at Moffitt Cancer Center have revealed a hidden layer of cellular intelligence that questions the traditional understanding of how cells operate.
Ron Gutman, inventor, serial healthcare and technology entrepreneur, and Stanford University adjunct professor, discusses the emergence of genomic sequencing as a vital tool in mitigating global public health threats.
The European Parliament voted to ease regulatory oversights on crops created through gene editing, which significantly departed from its longstanding suspicion towards genetically engineered organisms.
